PMID- 18644019 OWN - NLM STAT- MEDLINE DCOM- 20081231 LR - 20081006 IS - 1365-2133 (Electronic) IS - 0007-0963 (Linking) VI - 159 IP - 4 DP - 2008 Sep TI - Abnormal DNA methylation in T cells from patients with subacute cutaneous lupus erythematosus. PG - 827-33 LID - 10.1111/j.1365-2133.2008.08758.x [doi] AB - BACKGROUND: Impaired methylation of T-cell DNA is thought to contribute to the development of systemic lupus erythematosus. However, it is unknown whether T-cell hypomethylation is a factor in other, less severe, forms of lupus erythematosus such as subacute cutaneous lupus erythematosus (SCLE). OBJECTIVES: To investigate global DNA methylation and the expression of genes that regulate methylation in T cells of patients with SCLE. METHODS: We quantified global methylcytosine levels in CD4+ and CD8+ T cells from 12 patients with SCLE and nine healthy controls. mRNA levels of DNA methyltransferases (DNMTs), methylated CpG binding proteins (MBDs) and CD11a were measured by real-time quantitative polymerase chain reaction. RESULTS: CD4+ T-cell DNA from patients with SCLE was hypomethylated relative to controls (P = 0.002). DNMT1 and DNMT3a mRNA levels were significantly lower in CD4+ T cells from SCLE patients than in controls (P = 0.027 and P = 0.004, respectively). Relative to controls, MBD1, MBD3 and MBD4 mRNA levels were significantly higher in SCLE CD4+ cells (P < 0.001, P < 0.001 and P = 0.001, respectively), whereas MECP2 and MBD4 mRNA expression were significantly increased in SCLE CD8+ T cells (P = 0.001 and P = 0.001, respectively). DNMT1 expression positively correlated with CD4+ T-cell DNA methylation within our SCLE patient cohort (r = 0.590, P = 0.044). CD11a mRNA expression was significantly increased in SCLE CD4+ T cells relative to controls (P = 0.044) and negatively correlated with DNA methylation (r = -0.669, P = 0.049). CONCLUSIONS: These data suggest that aberrant regulation of DNA methylation in CD4+ T cells is associated with the development of SCLE. FAU - Luo, Y AU - Luo Y AD - Department of Dermatology, Epigenetic Research Centre, Second Xiangya Hospital, Central South University, Changsha, China. FAU - Li, Y AU - Li Y FAU - Su, Y AU - Su Y FAU - Yin, H AU - Yin H FAU - Hu, N AU - Hu N FAU - Wang, S AU - Wang S FAU - Lu, Q AU - Lu Q LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080717 PL - England TA - Br J Dermatol JT - The British journal of dermatology JID - 0004041 RN - EC 2.1.1.- (DNA Modification Methylases) SB - IM MH - Adult MH - Case-Control Studies MH - *DNA Methylation MH - DNA Modification Methylases/*genetics MH - Female MH - Gene Expression/genetics MH - Humans MH - Lupus Erythematosus, Cutaneous/*genetics/immunology MH - Male MH - Middle Aged MH - T-Lymphocytes/immunology/*metabolism EDAT- 2008/07/23 09:00 MHDA- 2009/01/01 09:00 CRDT- 2008/07/23 09:00 PHST- 2008/07/23 09:00 [pubmed] PHST- 2009/01/01 09:00 [medline] PHST- 2008/07/23 09:00 [entrez] AID - BJD8758 [pii] AID - 10.1111/j.1365-2133.2008.08758.x [doi] PST - ppublish SO - Br J Dermatol. 2008 Sep;159(4):827-33. doi: 10.1111/j.1365-2133.2008.08758.x. Epub 2008 Jul 17.